Cytori Therapeutics Inc (CYTX) 1.20 $CYTX Why Cytori

New Post Public Reply Private Reply Replies (0) Message Board

Mar 30, 2015 at 5:36 PM

Cytori Therapeutics Inc (CYTX) 1.20 $CYTX

Why Cytori Therapeutics (CYTX) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 7:58AM CDT
One stock that might be an intriguing choice for investors right now is Cytori Therapeutics as this security in the pharmaceutical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
CYTX: 1.20 (+0.01)

Cytori Launches Celase(R) GMP Product
Business Wire - Wed Mar 25, 7:00AM CDT
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it will formally launch and showcase its new Celase(R) GMP enzyme at the 2015 International Society for Cellular Therapy (ISCT) annual meeting on May 27th to 30th in Las Vegas. This will mark the first time that Cytori has made Celase(R) GMP available for purchase as a standalone product.
CYTX: 1.20 (+0.01)

Cytori Presents Thermal Burn Data at the 2015 American Burn Association Meeting
Business Wire - Mon Mar 23, 7:00AM CDT
Cytori Therapeutics, Inc. (NASDAQ:CYTX) will present data from two preclinical studies describing safety and efficacy of ADRCs for treatment of thermal burn injuries at the Annual Meeting of the American Burn Association (ABA) in Chicago on April 21-24, 2015. This research, funded by the contract with the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services, was part of the package of data submitted to the US Government as part of the In-Process Review meeting that led to the execution of the current contract option valued at $14.1 million, and part of Cytori's $106 million BARDA contract framework.
CYTX: 1.20 (+0.01)

Will Cytori Therapeutics (CYTX) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 7:14AM CDT
Will Cytori Therapeutics (CYTX) Continue to Surge Higher?
CYTX: 1.20 (+0.01)

Technical Coverage on Biotech Stocks -- Cytori Therapeutics, Oncolytics Biotech, BioMarin Pharma, Aeterna Zentaris, and Immunomedics
PR Newswire - Thu Mar 19, 8:05AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMMU: 3.89 (+0.18), BMRN: 129.13 (+0.35), ONCY: 0.77 (unch), CYTX: 1.20 (+0.01), AEZS: 0.53 (unch)

Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 8:19AM CDT

SD: 1.83 (+0.05), SSH: 4.16 (-0.02), PLUG: 2.68 (+0.04), BBX: 18.50 (+0.02), IMNP: 1.92 (+0.07), MGM: 21.27 (-0.03), DSW: 37.25 (+0.70), VEEV: 25.44 (-0.02), ESPR: 92.04 (+1.39), CYTX: 1.20 (+0.01), BDE: 9.71 (+0.09), ARTX: 3.12 (-0.04), ANTH: 4.53 (+0.21), WYY: 1.32 (+0.01), CJJD: 2.74 (+0.01), DSCO: 1.18 (+0.01)

Borrow Costs Elevated On CorMedix
Interactive Brokers - at Seeking Alpha - Tue Mar 17, 2:09AM CDT
CorMedix, Inc. (NYSEMKT: CRMD ) continues to be a difficult borrow as demand has far exceeded the lendable supply. Over the past two weeks the amount of shares traded in the cash market has been well above historical averages while the amount of...
CRMD: 8.70 (+0.56), EYES: 13.08 (-0.14), SHAK: 49.62 (+0.62), MELA: 2.78 (-0.21), GME: 37.69 (-0.67), AMRN: 2.39 (-0.02), AXN: 1.70 (-0.12), FXCM: 2.13 (-0.03), WBAI: 10.63 (-1.15), RESN: 7.54 (-1.14), WPRT: 4.05 (+0.02), RIG: 14.71 (+0.22), CYTX: 1.20 (+0.01), CEN: 17.50 (+0.39), CAPN: 6.06 (+0.05)

Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Mar 13, 6:19PM CDT

CYTX: 1.20 (+0.01)

Cytori Therapeutics (CYTX) Stock: Weak On High Volume Today
at The Street - Fri Mar 13, 9:03AM CDT
Trade-Ideas LLC identified Cytori Therapeutics (CYTX) as a weak on high relative volume candidate
CYTX: 1.20 (+0.01)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 8:14AM CDT

HIBB: 49.76 (+0.46), WLL: 30.72 (+0.22), ANN: 41.17 (-0.40), AXN: 1.70 (-0.12), CBPX: 20.88 (+0.41), CTIC: 1.87 (+0.06), FXCM: 2.13 (-0.03), ARO: 3.33 (+0.03), GENE: 4.94 (+1.24), ONVO: 3.37 (-0.29), CYTX: 1.20 (+0.01), LOCO: 25.81 (-0.16), GALE: 1.41 (+0.06), ULTA: 151.58 (+0.38), CUR: 1.95 (-0.06)

Cytori Therapeutics EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 3:57PM CDT

CYTX: 1.20 (+0.01)

Cytori Reports Fourth Quarter and Full Year 2014 Business and Financial Results
Business Wire - Thu Mar 12, 3:30PM CDT
Cytori Therapeutics (NASDAQ: CYTX) today announced its fourth quarter and year end 2014 business and financial results.
CYTX: 1.20 (+0.01)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 11:47AM CDT

BAK: 6.89 (-0.04), MELA: 2.78 (-0.21), ZGNX: 1.37 (+0.03), EOX: 0.77 (+0.01), MRD: 17.75 (+0.63), ULTR: 1.45 (+0.05), BLT: 12.87 (+0.13), RESN: 7.54 (-1.14), GBSN: 2.44 (-0.29), CYTX: 1.20 (+0.01), WRES: 0.93 (-0.02), MTL: 1.35 (+0.12), VRA: 16.28 (+0.19), CTP: 4.86 (+0.31), ENRJ: 1.47 (-0.03), CORT: 5.62 (+0.04), CBMG: 36.95 (-3.15), SPP: 1.85 (-0.06), CAPN: 6.06 (+0.05), SZYM: 3.00 (+0.20)

Most active Nasdaq-traded stocks
AP - Tue Mar 10, 12:41PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 26.68 (+0.01), GERN: 3.87 (+0.02), FB: 83.19 (-0.11), CYTX: 1.20 (+0.01), MSFT: 40.96 (-0.01), INTC: 31.46 (-0.54), GEVO: 0.21 (-0.04), AAPL: 126.37 (+3.12), CSCO: 27.65 (+0.52)

Next Week In Biotech: Kythera Ad Comm, Roth Conference, Zogenix Earnings
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BDSI: 10.51 (-3.38), OMED: 25.80 (-0.09), BIOA: 8.82 (-0.04), SUPN: 11.76 (-0.02), CTIC: 1.87 (+0.06), ALXA: 2.02 (+0.01), DSCI: 8.78 (+0.02), ANTH: 4.53 (+0.21), CYTX: 1.20 (+0.01), KYTH: 48.78 (+0.60), ANAC: 56.81 (+1.96), ATHX: 2.86 (-0.06), CRMD: 8.70 (+0.56), ACRX: 3.67 (-0.07), TROV: 7.00 (unch), ZGNX: 1.37 (+0.03), PETX: 16.53 (+0.28), RPRX: 8.54 (-0.03), IMUC: 0.50 (-0.01), PGNX: 5.82 (+0.03), SNTA: 2.33 (+0.03), BLCM: 22.65 (+0.19), TXMD: 6.20 (+0.20), OGXI: 2.15 (unch), AST: 7.05 (-0.42), PLX: 1.75 (-0.02), ATRS: 2.62 (+0.04)

Cytori preliminary Q4 product revenues $2.5M; 2015 revenue growth 0 - 60%
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 9:48AM CST

CYTX: 1.20 (+0.01)

Cytori Therapeutics (CYTX) Jumps: Stock Moves 7.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 8:25AM CST
Cytori Therapeutics (CYTX) was a big mover last session, with shares rising over 7% on the day.
CYTX: 1.20 (+0.01), AFFX: 12.86 (+0.15)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Puori Protein Transparency Pays Off Amid Lead Scare

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Vayo Debuts as Booking Holdings Eyes $100M Investment

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Omega Point's MCP Secures Anthropic Verification

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Wagner Logistics Gears Up for Major Expansion in Liberty

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Truck Drivers USA & Career Driver Unveil New Driver Agent

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Gourmia Introduces Ceramic-Coated Air Fryer at Costco

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

Marshall Goldman Expands Footprint with Marino Acquisition

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...